Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07604610 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian Populations

Study acronym: EPIGRAPH
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Visceral obesity is a well-established risk factor for the development of chronic non-communicable diseases (NCDs). Epicardial fat tissue (EFT) is located on the surface of the myocardium and may directly affect cardiac function and contribute to structural and functional remodeling. According to the literature, increased EFT thickness is associated with a wide range of NCDs, disease severity, and prognosis. The aim of this study is to investigate the associations between EFT thickness and clinical and anamnestic parameters, as well as to evaluate the prognostic value of this parameter in patients aged 50-70 years from the Russian Federation, Kazakhstan, Uzbekistan, and Kyrgyzstan.
Trial Details
NCT Number NCT07604610
Lead Sponsor National Medical Research Center for Therapy and Preventive Medicine
Conditions
(from sponsor)		 Epicardial Fat Tissue (EFT), Chronic Non-Communicable Diseases (NCDs), Visceral Obesity
Related terms Metabolic Diseases, Noncommunicable Diseases, Obesity, Abdominal
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov